Nowadays, the pharmaceutical market is growing rapidly and continuously in worldwide but, still the demand for new drug discovery is encouraged. Because, the growth of numbers drug resistant infectious disease and more upcoming disorders to human and animals. In general, the marine animals especially mollusks and their compounds constitute a practically unlimited resource of new active substances. Hence, the present study was carried out to determine the bactericidal activity of Crassostrea madrasensis protein against human pathogens. The edible Oyster Crassostrea madrasensis was collected from Rayapuram lnading centre, Tamil Nadu, India. Immediately it was extracted by using phosphate buffer at three different pH (4, 7 and 9) and all the extracts were screened against six different human pathogens such as Vibrio cholerae, V. parahaemolyticus, Salmonella sp, Shigella sp, Streptococcus sp and Staphylococcus sp by agar well diffusion assay. After 24 hrs of incubation the maximum inhibitory effect was observed against Vibrio parahaemolyticus, Streptococcus sp and Staphylococcus sp and the minimum inhibitory effect was observed against Vibrio cholerae, Salmonella sp and Shigella sp respectively. Whereas checking the minimal inhibitory concentration (MIC), the crude protein extract of Crassostrea madrasensis was inhibited the bacterial strains with the minimum inhibitory concentration of not less than 0.1ml (100¼l). The molecular weight of the crude protein was found from 12.2 to 74.2 kDa and the total protein content of phosphate buffer crude extract of Crassostrea madrasensis was found to be 312 ¼g/ mg. From, the results, the work has suggested to use this commercially available and protein rich (bactericidal) oyster in therapeutics for the development of novel antibiotics against multiple drug resistance (MDR) pathogenic microbes.
The growth of many drug resistant infectious disease and more upcoming disorders to human and animals are major problem in world wide. Antimicrobial protein (peptides) is become as new antibacterial substance because of their bioactivity against resistance bacteria. The terrestrial resources have been greatly explored. Nowadays, the researchers are expecting the lead molecules and compounds from the new resources especially. The Ocean covered more than 70% of the earth surface represent an enormous resource and from the past three to four decades many efforts have been committed for isolating various biologically active novel compounds from marine bio sources due to their huge biodiversity and which offers a potential chemicals which can be useful for finding new bioactive compounds with greater effectiveness and specificity against human and animal pathogens 1 . There are, more than 12,000 natural products have been isolated from Marine algae, sponges, coelenterates, ascidians, echinoderms and bryozoans 2 . Molluscs are a common prospect resource for the discovery of novel compounds for isolating bio active compounds to the pharmaceutical industry because most of the marine animals have lack of physical defenses, they produce toxic chemicals to protect themselves in a very hostile environment and still now most of them are unexplored 3 , 4 . Some studies have reported that, the bioactivity of the mollusks like Aplysia sp 5 , Phyllidae sp 6 , bivalves 7 , gastropods 8 , and their egg masses 9 . Moreover, marine invertebrates are known to depend on innate immune mechanisms by interacting cellular and humoral components to protect against pathogens for their safe 10 . The Crassostrea madrasensis is one of the edible and commercially available species and the metabolites or bioactive compounds are still unexplored 11 . Thus the present study was carried out to determine the bactericidal effect of commercially available and edible oyster Crassostrea madrasensis extract against six different human pathogens.
MATERIALS AND METHODS

Collection and Identification of Crassostrea madrasensis
The edible Oyster Crassostrea madrasensis was collected from Rayapuram landing centre, Tamil Nadu, India. The collected animals were identified by using standard manuals 12 .
Extraction of Bactericidal peptides
The edible Oyster Crassostrea madrasensis was collected and transferred to the laboratory and washed with distilled water and the flesh samples were taken by breaking the shells. The peptides were prepared from the whole body tissue by phosphate buffer saline at three different pH (4, 7 and 9) by standard homogenization procedure. The homogenized mixtures were centrifuged at 4°C in 7500 rpm for 30 min. The supernatant was obtained, Freeze dried and stored at -20°C.
The lyophilized crude extract was dissolved in 9.5 ml of phosphate buffer saline (PBS) at three different pH to obtain the partially purified protein by 85% ammonium sulfate precipitation and it was dialyzed 13 . The dialyzed solution was freeze dried and stored at -20°C. A stock solution of 2 mg/ml of lyophilized crude protein extract in sterilized PBS at three different pH(4, 7 and 9) was prepared for the further test 14 .
Bactericidal activity
The bactericidal potency of the crude protein extract of Crassostrea madrasensis was evaluated by adding 100¼l of each extract (water and phosphate buffer) against six different human pathogens such as Vibrio cholerae, V. parahaemolyticus, Salmonella sp, Shigella sp Streptococcus sp and Staphylococcus sp by agar well diffusion assay. After the 24 hrs incubation, the zone of inhibition (ZOI) around the wells was measured. The assay was repeated in triplicate and the averages of the three were given as results 15 .
MIC and MBC determination
The minimal inhibitory concentration (MIC) of the crude extract of Crassostrea madrasensis was determined by broth tube dilution assay. The Crassostrea madrasensis crude extract was prepared at various concentrations from 0.1ml to 0.5ml were determined for inhibitory level against all the human bacterial pathogens. The minimal inhibitory concentration (MIC) tubes were further carried out for Minimal Bactericidal concentration (MBC) evaluation using standard protocols. After 24 hrs of incubation period the loop full of cultures from the MIC and control tubes were transferred to the nutrient agar plates and the growth was monitored 16 .
SDS PAGE Analysis
The proteins in the crude extract of Crassostrea madrasensis were purified and the molecular weight was confirmed by SDS PAGE analysis 17 .
Estimation of protein concentration
The total protein concentration in the crude extract of Crassostrea madrasensis was estimated by the Lowry's method using BSA as standard 18 .
RESULTS AND DISCUSSION
In general, the marine invertebrates such as cephalopods, gastropods, bivalves secrete or emit some substances which have a role in the chemical defenses and act against their predators. Some studies also proven that the compounds isolated from mollusks have exhibiting several activities against human and animal pathogens 19 . It is estimated, there are more than thousand new compounds has been categorized from marine invertebrates such as peptides, terpenes, polypropionates, nitrogenous compounds, polypeptides, macrolides, prostaglandins and fatty acid products, sterols and diverse compounds 20 .
Among the marine invertebrates the bivalves possess several types of defense molecules including agglutinins and glycoproteins which have bactericidal activities 21 . In this present study, the edible Oyster Crassostrea madrasensis was collected from Rayapuram landing centre of Tamil Nadu, India (Fig 1) . Immediately it was extracted by using phosphate buffer at three different pH (4, 7 and 9) and all the extracts were screened against all the six different human pathogens such as Vibrio cholerae, V. parahaemolyticus, Salmonella sp, Shigella sp, Streptococcus sp and Staphylococcus sp by agar well diffusion assay and the zone around the wells were measured after incubation of 24 hrs (Table 1) . Moreover, in all the tested human pathogenic bacteria were mostly inhibited by the crude protein extract pH 7 of Crassostrea madrasensis and the maximum inhibitory effect of 14mm was observed against Vibrio parahaemolyticus, Streptococcus sp and Staphylococcus sp and the minimum inhibitory effect of 8mm was observed against Vibrio cholerae, Salmonella sp and Shigella sp respectively (Fig 2) . Similar results were also observed by previous studies 22 . In their study they have reported that the edible bivalves Perna viridis and M. casta have the ability to inhibit growth of pathogenic bacteria Staphylococcus aureus and Salmonella enteridis, which cause food borne illness 23 . Three different extracts of both M. meretrix and M. casta species against some pathogens, both the extracts have showed highest antibacterial activities against B.substillus, K.pneumonia and P.fluroscence respectively 23 .
Whereas checking the minimal inhibitory concentration (MIC) of the crude extract of
Crassostrea madrasensis against all the human pathogenic bacteria at different dilutions (such as, 0.1, 0.2, 0.3, 0.4 and 0.5ml) by broth tube dilution assay. The extract has inhibited the bacterial strains with the minimum inhibitory concentration of not less than 0.1ml (100¼l) of the extract. The pathogenic bacterial strains such as Vibrio parahaemolyticus, Streptococcus sp and Staphylococcus sp were inhibited at 200¼l and remaining pathogenic bacterial strains such as, Vibrio cholerae, Salmonella sp and Shigella sp were inhibited at 300 ¼l of Crassostrea madrasensis extract. Moreover the extracts also just inhibited the growth of many pathogenic bacteria at higher concentrations but not killed. The inhibitory and bactericidal concentration (MBC) remains same for extract of Crassostrea madrasensis against Vibrio cholerae, V. parahaemolyticus and Salmonella sp 26 . In general, antimicrobial peptides (AMPs) are also act as major components of innate immune defence system in invertebrates, because the innate immunity is triggered immediately when the microbial infection occurs 27 . From the results, the study has suggested to use this antibacterial peptides from Crassostrea madrasensis for the development of novel antibiotics against to multiple drug resistance (MDR) pathogenic microbes. 
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